Author(s):
Dwi Murtiastutik, M. Yulianto Listiawan, Lunardi Bintanjoyo, Afif Nurul Hidayati, Septiana Widyantari, Astindari, Maylita Sari
Email(s):
dwimurtiastutik@yahoo.co.id
DOI:
10.52711/0974-360X.2022.00179
Address:
Dwi Murtiastutik1*, M. Yulianto Listiawan1, Lunardi Bintanjoyo1, Afif Nurul Hidayati1,2, Septiana Widyantari1, Astindari1, Maylita Sari1
1Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya 60285, Indonesia.
2Universitas Airlangga Teaching Hospital, Surabaya 60115, Indonesia.
*Corresponding Author
Published In:
Volume - 15,
Issue - 3,
Year - 2022
Cite this article:
Dwi Murtiastutik, M. Yulianto Listiawan, Lunardi Bintanjoyo, Afif Nurul Hidayati, Septiana Widyantari, Astindari, Maylita Sari. Ketoconazole: A Re-emerging choice for Oral candidiasis in patients with human immunodeficiency virus infection/acquired Immunodeficiency Syndrome. Research Journal of Pharmacy and Technology. 2022; 15(3):1071-6. doi: 10.52711/0974-360X.2022.00179